seems like even the directors dont think its cheap enough to buy. Says it all, just on the wage and perks.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025